Literature DB >> 10502535

Are there environmental forms of systemic autoimmune diseases?

E V Hess1.   

Abstract

A large number of drugs and an increasing number of environmental agents reportedly result in the appearance of a number of autoantibodies and in many instances in the appearance of a range of autoimmune clinical syndromes. The major disorders so recognized have marked resemblances to the autoimmune disease systemic lupus erythematosus. The commonly used term is drug-induced lupus; a better term is drug-related lupus. There is considerable interest at the present time in an increasing number of environmental agents. There have been two epidemics in recent years--one in Spain to a contaminant of rapeseed oil and one in the United States to a contaminant of l-tryptophan that caused an eosinophilic myositis. It is important for physicians and others involved in health care to recognize the potential associations of these diseases of unknown cause or causes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502535      PMCID: PMC1566256          DOI: 10.1289/ehp.99107s5709

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  17 in total

1.  Lupus erythematosus disseminatus after administration of mesantoin; report of two cases.

Authors:  T LINDQVIST
Journal:  Acta Med Scand       Date:  1957-08-13

2.  Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects.

Authors:  J D MORROW; H A SCHROEDER; H M PERRY
Journal:  Circulation       Date:  1953-12       Impact factor: 29.690

3.  Hair product use in systemic lupus erythematosus. A case-control study.

Authors:  M Petri; J Allbritton
Journal:  Arthritis Rheum       Date:  1992-06

4.  Pancytopenia during ingestion of alfalfa seeds.

Authors:  M R Malinow; E J Bardana; S H Goodnight
Journal:  Lancet       Date:  1981-03-14       Impact factor: 79.321

5.  Is occupational organic solvent exposure a risk factor for scleroderma?

Authors:  P J Nietert; S E Sutherland; R M Silver; J P Pandey; R G Knapp; D G Hoel; M Dosemeci
Journal:  Arthritis Rheum       Date:  1998-06

6.  HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

Authors:  L Richeldi; R Sorrentino; C Saltini
Journal:  Science       Date:  1993-10-08       Impact factor: 47.728

7.  Immune alteration associated with exposure to toxic chemicals.

Authors:  A Vojdani; M Ghoneum; N Brautbar
Journal:  Toxicol Ind Health       Date:  1992 Sep-Oct       Impact factor: 2.273

8.  Serologic evaluation of patients receiving procainamide.

Authors:  A B Mongey; R Donovan-Brand; T J Thomas; L E Adams; E V Hess
Journal:  Arthritis Rheum       Date:  1992-02

9.  Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma.

Authors:  A Alonso-Ruiz; A C Zea-Mendoza; J M Salazar-Vallinas; A Rocamora-Ripoll; J Beltrán-Gutiérrez
Journal:  Semin Arthritis Rheum       Date:  1986-02       Impact factor: 5.532

10.  L-tryptophan and eosinophilia-myalgia syndrome in New Mexico.

Authors:  M Eidson; R M Philen; C M Sewell; R Voorhees; E M Kilbourne
Journal:  Lancet       Date:  1990-03-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.